BIOCRYST PHARMACEUTICALS INC
S-8, EX-23.1, 2000-06-16
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: BIOCRYST PHARMACEUTICALS INC, S-8, EX-5, 2000-06-16
Next: BIOCRYST PHARMACEUTICALS INC, S-8, EX-99.1, 2000-06-16


EXHIBIT 23.1

CONSENT OF ERNST & YOUNG LLP

INDEPENDENT AUDITORS

We consent to the incorporation by reference in this Registration Statement on Form S-8 pertaining to the 1991 Stock Option Plan of our report dated January 21, 2000, with respect to the financial statements of BioCryst Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 1999, filed with the Securities and Exchange Commission.



    /s/ Ernst & Young LLP
 
ERNST & YOUNG LLP
INDEPENDENT AUDITORS

Birmingham, Alabama
June 12, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission